A detailed history of Cape Investment Advisory, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 4,613 shares of JNJ stock, worth $674,236. This represents 0.34% of its overall portfolio holdings.

Number of Shares
4,613
Previous 4,769 3.27%
Holding current value
$674,236
Previous $748 Million 2.38%
% of portfolio
0.34%
Previous 0.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 21, 2024

SELL
$155.22 - $162.74 $24,214 - $25,387
-156 Reduced 3.27%
4,613 $730 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $44,699 - $48,776
307 Added 6.88%
4,769 $748 Million
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $185,965 - $208,329
-1,194 Reduced 21.11%
4,462 $695 Million
Q2 2023

Oct 12, 2023

BUY
$154.35 - $166.11 $42,600 - $45,846
276 Added 5.13%
5,656 $936 Million
Q1 2023

Oct 12, 2023

BUY
$151.05 - $180.26 $812,649 - $969,798
5,380 New
5,380 $834 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cape Investment Advisory, Inc. Portfolio

Follow Cape Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cape Investment Advisory, Inc. with notifications on news.